Ketorolac versus morphine for severe pain. Ketorolac is more effective, cheaper, and has fewer side effects
- PMID: 11082068
- PMCID: PMC1118996
- DOI: 10.1136/bmj.321.7271.1236
Ketorolac versus morphine for severe pain. Ketorolac is more effective, cheaper, and has fewer side effects
Comment on
-
Cost effectiveness analysis of intravenous ketorolac and morphine for treating pain after limb injury: double blind randomised controlled trial.BMJ. 2000 Nov 18;321(7271):1247-51. doi: 10.1136/bmj.321.7271.1247. BMJ. 2000. PMID: 11082083 Free PMC article. Clinical Trial.
References
-
- Tramer MR, Williams JE, Carroll D, Wiffen PJ, Moore RA, McQuay HJ. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Cochrane Database of Abstracts of Reviews of Effectiveness. The Cochrane Library, 1999. CRD database number: DARE-980293 - PubMed
-
- Gillis JC, Brogden RN. Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs. 1997;53:139–188. - PubMed
-
- Strom BL, Berlin JA, Kinman JL, Spitz PW, Hennessy S, Feldman H, et al. Parenteral ketorolac and risk of gastrointestinal and operative site bleeding. A postmarketing surveillance study. JAMA. 1996;275:376–382. - PubMed
-
- Jelinek GA. Casemix classification of patients attending hospital emergency departments in Perth, Western Australia. Development and evaluation of an urgency-based casemix information system for emergency departments [thesis]. University of Western Australia; 1995.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical